89bio, Inc
$24.779876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$24.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.61 (+2.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell 89bio, Inc and other stocks, options, and ETFs commission-free!
About ETNB
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases.
CEO
Rohan Palekar
Employees
27
Headquarters
San Francisco, California
Founded
2018
Market Cap
480.78M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.98K
High Today
$24.86
Low Today
$23.91
Open Price
$24.31
Volume
128.50K
52 Week High
$42.36
52 Week Low
$18.01
Analyst Ratings
100%
of 7 ratings
Buy
100%
Hold
0%
Sell
0%
ETNB Earnings
-$30.63
-$20.42
-$10.21
-$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 12, After Hours